Hennion & Walsh Asset Management, Inc. Applied Therapeutics Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.1 Billion
- Q4 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 313,355 shares of APLT stock, worth $191,146. This represents 0.01% of its overall portfolio holdings.
Number of Shares
313,355
Previous 265,372
18.08%
Holding current value
$191,146
Previous $2.26 Million
88.2%
% of portfolio
0.01%
Previous 0.11%
Shares
3 transactions
Others Institutions Holding APLT
# of Institutions
140Shares Held
112MCall Options Held
1.68MPut Options Held
1.91M-
Janus Henderson Group PLC London, X010.5MShares$6.43 Million0.05% of portfolio
-
Morgan Stanley New York, NY9.9MShares$6.04 Million0.01% of portfolio
-
Vr Adviser, LLC New York, NY9.83MShares$5.99 Million8.65% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$4.88 Million1.78% of portfolio
-
Franklin Resources Inc San Mateo, CA6.8MShares$4.15 Million0.02% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $29.3M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...